FDA Streamlines 510(k) Process, As Courts Reconsider It

By Caitlin McHugh and Matthew Smith (November 15, 2018, 12:39 PM EST) -- Change is in store for the Section 510(k) substantial equivalence approval process for Class II medical devices, both from the U.S. Food and Drug Administration and the courts. The FDA is working to streamline and expedite the Section 510(k) process, just as courts are giving more credence to the argument that Section 510(k) review and approval results in a finding of safety and effectiveness by the FDA — a trend which could have significant implications for punitive damages claims brought against manufacturers of Class II devices....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!